Isoalantolactone ameliorates ulcerative colitis via gut microbiota-mediated modulation of intestinal barrier, T cell homeostasis, and metabolite reprogramming
European Journal of Pharmacology · 2026-04 · 1020 · 178798
DOI: 10.1016/j.ejphar.2026.178798 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Pharmacology, 2026-04. Verfasst von Fei Lin und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Functional Food and Wine, Shenyang Pharmaceutical University, Wenhua Road 103, Shenyang, Liaoning Province, 110016, China. Electronic addre…. Hauptthemen laut MEDLINE: Colitis, Ulcerative, Sesquiterpenes, Gastrointestinal Microbiome, T-Lymphocytes. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 59 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Liaoning Revitalization Talents Program, Shenyang Pharmaceutical University.
Abstract (Originalsprache)
Ulcerative colitis (UC) is a chronic inflammatory bowel disease characterized by immune dysregulation, epithelial barrier dysfunction, and gut microbiota imbalance. This study examined the therapeutic potential of isoalantolactone (IAL), a bioactive sesquiterpene lactone naturally occurring in Inula helenium L., using a dextran sulfate sodium-induced murine colitis model. Treatment with IAL significantly mitigated weight loss, improved the disease activity index, preserved colon length, and alleviated goblet cell depletion. Mechanistically, IAL enhanced intestinal barrier integrity by upregulating tight-junction proteins zonula occludens-1, occludin, and mucin 2 and suppressing proinflammatory cytokines interleukin (IL)-6, tumor necrosis factor-α, and IL-1β. Moreover, IAL rebalanced CD4+/CD8+ T cell ratios in the colon, mesenteric lymph nodes, and spleen. Gut microbiota analysis revealed increased diversity, enrichment of beneficial taxa (Muribaculaceae, Prevotellaceae_UCG-001), and a reduced Firmicutes-to-Bacteroidetes ratio. Metabolomic profiling identified 130 differentially abundant metabolites, including increased levels of anti-inflammatory compounds (e.g., hydroferulic acid) and decreased levels of proinflammatory lipids (e.g., linoleoylcarnitine). Correlation analysis demonstrated an association between gut microbiota and faecal metabolites. In addition, faecal microbiota transplantation confirmed that IAL-modulated microbiota ameliorated colitis, with pseudo-germ-free recipients exhibiting improved barrier function and immune homeostasis. These findings highlight the importance of IAL as a novel therapeutic candidate for UC by modulating host-microbiota interactions; however, clinical validation is warranted.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Functional Food and Wine, Shenyang Pharmaceutical University, Wenhua Road 103, Shenyang, Liaoning Province, 110016, China. Electronic address: linfei_9804@163.com.
- School of Functional Food and Wine, Shenyang Pharmaceutical University, Wenhua Road 103, Shenyang, Liaoning Province, 110016, China. Electronic address: zhangdh_0122@163.com.
- School of Functional Food and Wine, Shenyang Pharmaceutical University, Wenhua Road 103, Shenyang, Liaoning Province, 110016, China. Electronic address: 15755768135@163.com.
- School of Functional Food and Wine, Shenyang Pharmaceutical University, Wenhua Road 103, Shenyang, Liaoning Province, 110016, China. Electronic address: 1073950834@qq.com.
- School of Functional Food and Wine, Shenyang Pharmaceutical University, Wenhua Road 103, Shenyang, Liaoning Province, 110016, China. Electronic address: jinyuwang0214@126.com.
- School of Functional Food and Wine, Shenyang Pharmaceutical University, Wenhua Road 103, Shenyang, Liaoning Province, 110016, China. Electronic address: 107000109@syphu.edu.cn.
Förderung
- National Natural Science Foundation of China
- Liaoning Revitalization Talents Program
- Shenyang Pharmaceutical University
- China Postdoctoral Science Foundation
Zitieren
APA
Lin, F., Zhang, D., Liu, S., Wu, B., Wang, J., Yan, T., & Jia, Y. (2026). Isoalantolactone ameliorates ulcerative colitis via gut microbiota-mediated modulation of intestinal barrier, T cell homeostasis, and metabolite reprogramming. European Journal of Pharmacology, 1020, 178798. https://doi.org/10.1016/j.ejphar.2026.178798
Vancouver
Lin F, Zhang D, Liu S, Wu B, Wang J, Yan T, et al. Isoalantolactone ameliorates ulcerative colitis via gut microbiota-mediated modulation of intestinal barrier, T cell homeostasis, and metabolite reprogramming. European Journal of Pharmacology. 2026;1020:178798. doi:10.1016/j.ejphar.2026.178798
BibTeX
@article{Lin2026,
author = {Lin, Fei and Zhang, Dehong and Liu, Saisai and Wu, Bo and Wang, Jinyu and Yan, Tingxu and Jia, Ying},
title = {Isoalantolactone ameliorates ulcerative colitis via gut microbiota-mediated modulation of intestinal barrier, T cell homeostasis, and metabolite reprogramming},
journal = {European Journal of Pharmacology},
year = {2026},
volume = {1020},
pages = {178798},
doi = {10.1016/j.ejphar.2026.178798}
}
EUVIMED